Regulatory

Excerpt of ProJect Pharmaceutics’ Quality Management System (QMS):

  • Based on the guidelines for pharmaceutical development of the International Conference on Harmonization (ICH)
  • Based on the “Good practices for research and development facilities” guidelines of the World Health Organization (WHO), Nov. 2020
  • Based on the requirements of ISO certification: 
    • Organigram, Responsibilities and Authorization, Technical Equipment, Analytical Methods, Map of Processes, Matrix of Communication
    • SOP (Standard Operating Procedures) system for i.a. analytical methods, qualification and maintenance of technical equipment, processes, documentation
    • Regularly maintained and calibrated measuring systems
    • Qualified test methods and Pharmacopoeia methods
    • Certified excipients
    • Quality-by-design (QbD) approaches
    • Electronic lab journals
    • Long-term data storage (central and external server, backed up daily)
    • Alarm circuits
    • Staff qualification & continuous staff training
  • Complies with GLP-like quality standards (standards for non-clinical R&D)
  • No GMP required
  • Documentation complies with standards for submission to authorities 
    • Design of experiment (DoE, protocol)
    • Execution of task (raw data + evaluation)
    • Documentation (electronic lab journal)
    • Detailed final development report (“four-eyes principle”): Materials, methods, experimental design, results and conclusions described in detail. All raw data stored properly and provided on demand.